Idelberto Raul Badell
7PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Nov 02, 2022
Impact of belatacept and tacrolimus on cytomegalovirus viral load control and relapse in moderate and high-risk cytomegalovirus serostatus kidney transplant recipients.Wairimu Magua, Aileen C Johnson, Geeta M Karadkhele
|Nov 10, 2021
Temporal trends and current use of de novo belatacept in kidney transplant recipients in the United States.Geeta Karadkhele, Charlotte Duneton, Rouba Garro
|Feb 14, 2021
Every 2-month belatacept maintenance therapy in kidney transplant recipients greater than 1-year posttransplant: A randomized, noninferiority trial.Idelberto R Badell, Ronald F Parsons, Geeta Karadkhele
|May 15, 2020
Superior inhibition of alloantibody responses with selective CD28 blockade is CTLA-4 dependent and T follicular helper cell specific.Glenn Michael La Muraglia, Susan Zeng, Emma S Crichton
|Aug 28, 2019
The impact of belatacept on third-party HLA alloantibodies in highly sensitized kidney transplant recipients.Ronald F Parsons, Arslan Zahid, Shalini Bumb
|Jun 29, 2019
Circulating T follicular helper cells are a biomarker of humoral alloreactivity and predict donor-specific antibody formation after transplantation.Glenn Michael La Muraglia, Maylene E Wagener, Mandy L Ford
Pageof 2
Frequent Collaborators
3 joint publications
Christian P Larsen
3 joint publications
Mandy L Ford
2 joint publications
Ronald F Parsons
2 joint publications
Glenn Michael La Muraglia
1 joint publications
Grace S Kim
1 joint publications
John J Hanfelt
1 joint publications
Stephen O Pastan
1 joint publications
Wairimu Magua
1 joint publications
Aileen C Johnson
1 joint publications
Geeta M Karadkhele
